Back to search results

A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium

Abroad (travel likely)Recruiting

Conditions

Parkinson's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Universitair Ziekenhuis Antwerpen /ID# 279434, Edegem, Antwerpen, Belgium

  • Chu Tivoli /ID# 279455, La Louvière, Hainaut, Belgium

  • Centre Hospitalier De Wallonie Picarde - Site Notre Dame /ID# 279452, Tournai, Hainaut, Belgium

  • Jessa Ziekenhuis - Campus Virga Jesse /ID# 279454, Hasselt, Limburg, Belgium

  • UZ Gent /ID# 279433, Ghent, Oost-Vlaanderen, Belgium

  • Universitair Ziekenhuis Leuven /ID# 279439, Leuven, Vlaams-Brabant, Belgium

  • AZ Sint-Jan Brugge /ID# 279422, Bruges, West-Vlaanderen, Belgium

  • Az Groeninge Campus Kennedylaan /ID# 279423, Kortrijk, West-Vlaanderen, Belgium

  • AZ Oostende /ID# 279461, Ostend, West-Vlaanderen, Belgium

  • AZ-Delta. /ID# 279437, Roeselare, West-Vlaanderen, Belgium

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)